Kutatási jelek – Signal Engine

• Gastrointestinal Stromal Tumor — Gastrointestinal stromal tumor
• Adrenal gland tumours — Adrenocortical carcinoma
• Five-Year Follow-Up Results of OPTIC Clinical Trial for CML — Chronic myeloid leukemia
• Review Highlights Endocrinologists' Crucial Role in Diagnosing and Treating Adrenocortical Carcinoma — Adrenocortical carcinoma
• Hodgkin Lymphoma Treatment (PDQ®) — Hodgkin lymphoma
• Review of Genomic Testing and SDH Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST — Gastrointestinal stromal tumor
• UCSF Squamous Cell Carcinoma Trial: JNJ‑90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA‑HNSCC — Head and neck squamous cell carcinoma
• Cancer vaccine shows promise for patients with stage III and IV kidney cancer — Renal cell carcinoma
• Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma — Melanoma
• Clinical Trial Evaluates Promising Combination Therapy for Metastatic Uveal Melanoma - Roswell Park Comprehensive Cancer Center — Melanoma
• Primary Myelofibrosis — Chronic myeloid leukemia
• Breaking Ground: Successful Treatment Options for RET-Positive Lung Cancer — NSCLC
• Cholangiocarpinoma Clinical Trials - Rare Disease Advisor — Cholangiocarcinoma
• Effectiveness and Safety of Treatments for Early-Stage Merkel Cell Carcinoma: A Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies — Merkel cell carcinoma
• Canine Osteosarcoma Clinical Trial | ELIAS Animal Health — Breast cancer
• European Commission expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer — Endometrial cancer
• Appraising the Use of JAK Inhibitors in Treating Myelofibrosis — Myelofibrosis
• Clinical trial of HPV mRNA testing for uterine cervical cancer screening in Kitakyushu city — Cervical cancer
• Tumor Treating Fields (TTFields) for Pleural Mesothelioma — Malignant pleural mesothelioma
• Researchers uncover what drives aggressive bone cancer — Osteosarcoma